Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
PE-22-28 10mg PE-22-28 is a potent PACAP analog used in research on neuroprotection, cellular signaling, and oxidative stress
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
The peptides classification as a growth hormone fragment places it in a unique category
You're iron or folic acid deficient
Supplements like Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) are precursors that the body can use to synthesize NAD+, offering potential avenues for repletion
That said, the compound has not been through full Phase III trials or FDA drug approval
